Okinawa

Data cited: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years 1990-2016. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2018.   The Global Burden of Disease Study 2016 (GBD 2016), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 195 countries and territories and at the subnational level for a subset of countries. Estimates for deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs), years of life lost (YLLs), prevalence, and incidence for 29 cancer groups by age and sex for 1990-2016 are available from the GBD Results Tool. Files available in this record are the web tables published in JAMA Oncology in June 2018 in "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 29 Cancer Groups, 1990 to 2016."

Global Burden of Disease Study 2016 (GBD 2016) Healthcare Access and Quality Index Based on Amenable Mortality 1990–2016. Global Burden of Disease Study 2016 (GBD 2016) estimates were used in an analysis of personal healthcare access and quality for 195 countries and territories, as well as selected subnational locations, over time. This dataset includes the following global, regional, national, and selected subnational estimates for 1990-2016: age-standardized risk-standardized death rates from 24 non-cancer causes considered amenable to healthcare; age-standardized mortality-to-incidence ratios for 8 cancers considered amenable to healthcare; and the Healthcare Access and Quality (HAQ) Index and individual scores for each of the 32 causes on a scale of 0 to 100. Code used to produce the estimates is also included. Results were published in The Lancet in May 2018 in "Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

Data cited at: Prof.Prof. Lauren Gardner; Center for Systems Science and Engineering at John Hopkins University, blog Post -  https://systems.jhu.edu/research/public-health/ncov/   On December 31, 2019, the World Health Organization (WHO) was informed of an outbreak of “pneumonia of unknown cause” detected in Wuhan City, Hubei Province, China – the seventh-largest city in China with 11 million residents. As of February 04, 2020, there are over 24,502 cases confirmed globally, including cases in at least 30 regions in China and 30 countries.  Interests: In-Market Segments Knoema All Users   Knoema modified the original dataset to include calculations per million.   https://knoema.com/WBPEP2018Oct https://knoema.com/USICUBDS2020 https://knoema.com/NBSCN_P_A_A0301 https://knoema.com/IMFIFSS2017Nov https://knoema.com/AUDSS2019 https://knoema.com/UNAIDSS2017 https://knoema.com/UNCTADPOPOCT2019Nov https://knoema.com/WHOWSS2018 https://knoema.com/KPMGDHC2019

Data cited at: (https://www.numbeo.com/cost-of-living/historical-prices-by-city?displayCurrency=USD&year=2016&itemId=13)

We define our day as midnight-to-midnight, Pacific time. Cities represent usage in greater metropolitan areas and are stably defined during this period. In many countries/regions and cities, relative volume has increased since January 13th, consistent with normal, seasonal usage of Apple Maps. Day of week effects are important to normalize as you use this data. Data that is sent from users’ devices to the Maps service is associated with random, rotating identifiers so Apple doesn’t have a profile of your movements and searches. Apple Maps has no demographic information about our users, so we can’t make any statements about the representativeness of our usage against the overall population. This information will be available for a limited time during the COVID‑19 pandemic.